Five BUMC Faculty Members Elected AAAS Fellows
The American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of the journals Science, Science Translational Medicine and Science Signaling has named five members of the Boston University Medical Campus (BUMC) community AAAS Fellows.
They are: BU School of Medicine (BUSM) faculty David Michael Center, MD; Ronald B. Corley, PhD; Katya Ravid, Ph.D; and David J. Salant, MD; and Josée Dupuis, PhD, from BU School of Public Health (SPH).
The AAAS selects members whose work has helped to advance science and its applications. Now in its 140th year, 401 applicants will be awarded the title of fellow at the annual Fellows Forum in San Jose, Calif., in February.
David Center, MD, Associate Provost for Translational Research, Director of BUMC Translational Research Institute and Chief of Pulmonary, Allergy and Critical Care Medicine at Boston Medical Center (BMC) was elected as a fellow under the Section on Medical Sciences for his contributions to the field of Immunology, particularly for the discovery of the first human (IL-16) and virus-derived (HIV-1 gp120) lymphocyte chemotactic factors.
Ronald Corley, PhD, Professor of Microbiology, and Director at the National Emerging Infectious Diseases Laboratories, was elected as a fellow under the Section on Medical Sciences for his contributions to the field of immunology, particularly in elucidating innate functions of antibodies and B cells and their roles in accelerating adaptive immunity.
Josée Dupuis, PhD, Professor and Associate Chair of Biostatistics, was elected as a fellow under the Section on Biological Sciences for her contributions to the field of statistical genetics, leading to the discovery and improved understanding of the genetic basis for common diseases.
Katya Ravid, DSc, PhD, Professor of Medicine and Biochemistry, and Founding Director of the Evans Center for Interdisciplinary Biomedical Research, was elected as a fellow under the Section on Medical Sciences for pursuing interdisciplinary research, and outstandingly combining the fields of hematology and vascular biology, leading to the discovery of transcriptional and cell cycle signatures that govern polyploidy during megakaryocyte/platelet development.
David Salant, MD, Professor of Pathology and Laboratory Medicine, BUSM and Chief of the Section of Nephrology at BMC, was elected as a fellow under the Section on Medical Sciences for his contributions to the field of immunological kidney diseases, particularly for discovering that the anti-phospholipase A2 receptor is the major autoantigen in human membranous nephropathy.
Submitted by Amanda Macone, MD.